MedTrace Logo

Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant

NCT00148252 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 298

Last updated 2012-06-07

No results posted yet for this study

Summary

To compare the change in renal function between CsA or MMF withdrawal from before to 12 months after drug withdrawal in renal transplant recipients on triple immunosuppressive therapy

Conditions

  • Renal Transplantation

Interventions

DRUG

Mycophenolate mofetil withdrawal

DRUG

Cyclosporione A withdrawal

Sponsors & Collaborators

  • University of Oslo School of Pharmacy

    lead OTHER

Principal Investigators

  • Anders Åsberg, MSc · University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Primary Completion
2005-11-30
Completion
2007-02-28

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00148252 on ClinicalTrials.gov